New Delhi: For decades, German homoeopathy brands have enjoyed a premium global reputation, often being perceived as the gold standard in quality, consistency, and research-backed manufacturing. However, experts now believe that India—home to one of the world’s largest homoeopathy ecosystems—is on the brink of not only matching but surpassing German brands, driven by two powerful quality frameworks: the AYUSH Premium Mark and NABL accreditation.
Mr. Rajeshwar Tiwari, A senior representative from Ministry of AYUSH said “India has unmatched clinical data, practitioner strength, and patient diversity in homoeopathy. When this experiential advantage is supported by certified quality frameworks like AYUSH Premium and NABL, Indian homoeopathy gains scientific credibility that is globally comparable. This integration of research, regulation, and manufacturing excellence is essential for competing with established European brands.”
Mr. Adesh Sharma, CEO of Adven Biotech, which has become India’s first homoeopathy company to receive both the AYUSH Premium Mark and NABL certification Said “ this moment marks a turning point for Indian homoeopathy. AYUSH Premium and NABL are not just certificates; they are global passports for Indian homoeopathy,” For years, Indian brands were clinically strong but undervalued internationally due to lack of globally recognised quality benchmarks. These certifications change that perception completely and put Indian companies on the same platform as leading German manufacturers.”
Dr Pradeep Prajapati, Director of All India Institute of Ayurveda New Delhi Said “ The key differentiator lies in certified quality and scientific validation. The AYUSH Premium Mark, launched by the Ministry of AYUSH, represents global-level compliance in manufacturing, safety, and quality management for AYUSH products. NABL (National Accreditation Board for Testing and Calibration Laboratories) certification, on the other hand, ensures internationally benchmarked accuracy, reliability, and reproducibility in testing and quality control—aligned with ISO standards recognized across Europe and beyond.
Mr. Adesh Sharma further highlights how India stands to gain strategically.“Germany may have legacy, but India has scale, talent, raw material strength, and now certified quality. When Indian brands combine NABL-backed testing accuracy with AYUSH Premium manufacturing standards, we can offer products that are globally trusted yet significantly more accessible. This is how India doesn’t just compete with German homoeopathy—we outperform it,” .
Mr. Adesh Sharma further added “We aligned our internal systems with international norms—right from raw material authentication and in-process checks to final product validation. NABL forced us to measure everything scientifically, while AYUSH Premium ensured holistic compliance across manufacturing and governance. It was challenging, but it has transformed our organization,”.
Experts point out that this transformation is critical at a time when global consumers are becoming more discerning. Markets in Europe, the Middle East, Latin America, and Africa are demanding evidence of quality, safety, and consistency, not just tradition. German brands historically benefited from strong regulatory backing and standardized pharmacopeia. India is now closing that gap rapidly.
From an economic standpoint, the opportunity is significant. India already supplies homoeopathic medicines to over 100 countries, yet premium markets in Europe have remained relatively underpenetrated by Indian brands. With internationally aligned certifications, experts estimate that Indian homoeopathy exports could grow 2–3 times in the next five to seven years, especially in regulated markets.
Another major advantage India holds over Germany is cost-efficiency without compromising quality. While German homoeopathy products often come at a premium price, certified Indian brands can deliver comparable standards at a more competitive cost—making them attractive to both governments and consumers globally.
In the coming years, experts say, the real competition with German brands will not be about legacy, but about who delivers the most reliable, transparent, and globally compliant homoeopathic solutions. With AYUSH Premium and NABL as strong pillars, India appears ready not just to stand shoulder to shoulder with Germany—but to lead the next chapter of global homoeopathy.